Table 1.
Ferroptosis | Apoptosis | Autophagy | Necroptosis | |
---|---|---|---|---|
Morphological Features | Small mitochondria with increased mitochondrial membrane densities, reduction or vanishing of mitochondria Crista, outer mitochondrial membrane Rupture and normal nucleus | Cellular and nuclear volume reduction, chromatin agglutination, nuclear fragmentation, formation of apoptotic bodies and cytoskeletal disintegration, no significant changes in mitochondrial structure | Formation of double-membraned autolysosomes, including macroautophagy, microautophagy and chaperone-mediated autophagy | Plasma membrane breakdown, generalized swelling of the cytoplasm and organelles, moderate chromatin condensation, spillage of cellular constituents into the microenvironment |
Biochemical Features | Iron accumulation and lipid peroxidation | DNA fragmentation | Increased lysosomal activity | Drop in ATP levels |
Regulatory Pathways | Xc- /GPX4, MVA, sulfur transfer pathway, P62-Keap1-NRF2 pathway, P53/SLC7A11, ATG5-ATG7-NCOA4 pathway, P53-SAT1-ALOX15 pathway, HSPB1-TRF1, FSP1-COQ10-NAD(P)H pathway | Death receptor pathway, mitochondrion pathway and endoplasmic reticulum pathway; Caspase, P53, Bcl-2 mediated signaling pathway | mTOR, Beclin-1, P53 signaling pathway | TNF-R1 and RIP1/RIP3-MLKL related signaling pathways; PKC-MAPK-AP-1 related signaling pathway; ROS-related metabolic regulation pathway |
Key genes | GPX4, TFR1, SLC7A11, NRF2, NCOA4, P53, HSPB1, ACSL4, FSP1 | Caspase, Bcl-2, Bax, P53, Fas | ATG5, ATG7, LC3, Beclin-1, DRAM3, TFEB | RIP1, RIP3 |
ACSL4 acyl-CoA synthetase long-chain family member 4, ALOX-15 arachidonate lipoxygenase 15, AP-1 activator protein-1, ATG5 autophagy-related 5, ATG7 autophagy-related 7, COQ10 coenzyme Q10, DRAM3 damage-regulated autophagy modulator 3, FSP1 ferroptosis suppressor protein 1, GPX4 glutathione peroxidase 4, HSPB1 heat shock protein beta-1, Keap1 Keleh-like ECH-associated protein 1, MAPK mitogen-activated protein kinase, MLKL mixed lineage kinase domain like protein, mTOR mammalian target of rapamycin, MVA mevalonate, LC3 microtubule-associated protein 1 light chain3, NCOA4 nuclear receptor coactivator 4, NRF2 nuclear factor erythroid 2-related factor 2, PKC protein kinase C, RIP receptor-interacting serine/threonine kinase, ROS reactive oxygen species, SAT1 spermidine/spermine N1-acetyltransferase 1, SLC7A11 solute carrier family 7 member 11, system Xc- cysteine/glutamate transporter receptor, TFEB transcription factor EB, TFR1 transferrin receptor 1, TNF-R1 tumor necrosis factor R1.